Project Details
Abstract
Alteration of the microenvironment in the spinal cord is responsible for the central sensitization of the
neuropathic pain after the peripheral nerve injury. Except for neurons, glial cells and inflammatory cells
extravasated from circulation through the compromised blood‐spinal cord barrier (BSCB) take parts in
the central sensitization in the spinal cord. Glial cells in the spinal cord are activated in response to the
peripheral nerve injury and upregulate their production of proinflammatory cytokines, which in turn
disrupt the BSCB and exacerbate the hypersensitization of the neurons. In addition to the increased
proinflammatory cytokines, fibronectin (FN), a principle component of extracellular matrix (ECM), has
recently been shown an important role in the pain mechanism. Generally, the expression of FN in the
spinal cord is limited to little amount in the subendothelial matrix of the microvessels. FN matrix
deposition is significantly increased in the spinal cord microvessels and parenchyma in animals suffering
neuropathic pain. Via binding to its cell surface receptor, integrin, FN is known to promote glial cell
activation and dissociate endothelial cell‐cell adhesion complex leading to a leaky endothelial barrier.
Therefore, we hypothesize that the robust expression of FN in the spinal cord after peripheral nerve
injury may contribute to initiate the neuropathic pain in animals. In this proposal, we will test the
hypothesis that inhibiting FN matrix assembly decouples the interaction of FN and integrin thus blocks
the integrin‐induced signaling in glial and endothelial cells. In addition, inhibiting FN polymerization also
attenuates the neuropathic pain in animals following peripheral nerve injury. The aims are: 1) to
ascertain whether inhibiting FN polymerization restores the TNF‐‐induced endothelial barrier
dysfunction by blocking integrin activation and the subsequent intracellular signaling; 2) to determine
whether inhibition of FN polymerization decreases the integrin‐induced intracellular signaling and
cytokine/chemokine production in FN‐activated spinal microglia and astrocyte; 3) to determine whether
inhibition of FN polymerization by administrating FN polymerization inhibitor into animals subjected to
the peripheral nerve injury decreases neuropathic pain. These results will provide us an insight to
understand the mechanism in which FN regulate neuropathic pain and lead to the development of a
treatment strategy for neuropathic pain in the future.
Project IDs
Project ID:PC10108-0907
External Project ID:NSC101-2320-B182-004
External Project ID:NSC101-2320-B182-004
Status | Finished |
---|---|
Effective start/end date | 01/08/12 → 31/07/13 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.